Association Between Globulin and Diabetic Nephropathy in Type2 Diabetes Mellitus Patients: A Cross-Sectional Study.
Wang J, Liu F, Kong R, Han X.
Front Endocrinol (Lausanne). 2022 Jul 8;13:890273. doi: 10.3389/fendo.2022.890273. eCollection 2022.
PMID:35898464
Combine and Conquer: With Type 2 Diabetes Polypharmacy Is Essential Not Only to Achieve Glycemic Control but Also to Treat the Comorbidities and Stabilize or Slow the Advancement of Diabetic Nephropathy.
Bell DSH.
J Diabetes Res. 2022 Aug 4;2022:7787732. doi: 10.1155/2022/7787732. eCollection 2022.
PMID:35967126
miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy.
Akpınar K, Aslan D, Fenkçi SM, Caner V.
Diagnosis (Berl). 2022 Aug 18;9(4):499-507. doi: 10.1515/dx-2022-0036. eCollection 2022 Nov 1.
PMID:35976169
Direct medical cost of nephropathy in patients with type 2 diabetes.
Gülümsek E, Keşkek ŞÖ.
Int Urol Nephrol. 2022 Jun;54(6):1383-1389. doi: 10.1007/s11255-021-03012-4. Epub 2021 Oct 18.
PMID:34661824
The relationship between diabetic retinopathy and diabetic nephropathy in type 2 diabetes.
Wang Q, Cheng H, Jiang S, Zhang L, Liu X, Chen P, Liu J, Li Y, Liu X, Wang L, Li Z, Cai G, Chen X, Dong Z.
Front Endocrinol (Lausanne). 2024 Jan 26;15:1292412. doi: 10.3389/fendo.2024.1292412. eCollection 2024.
PMID:38344659
Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis.